Sanofi Aventis

Dengue vaccine possible, though not any time soon

Inital trials of the dengue vaccine that were carried out in Thailand have been less than encouraging with only 30 percent efficacy and more research will be required.

Bitter pill for Sun Pharma, Sanofi wins US drug ruling

French drugmaker Sanofi has scored an important victory in a patent dispute with Sun Pharmaceuticals that will keep generic copies of its Eloxatin colon cancer drug off the United States market until August 2012.